NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.09% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.09% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.84% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.83% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.66% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.66% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.54% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.51% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.48% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.45% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.45% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.39% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.38% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.30% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 1.27% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.26% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.14% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 1.13% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.07% |